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ABSTRACT
Objective: To examine the quality of HIV sero-
surveillance systems in 127 low-income and middle-
income countries by 2007, as well as gaps in data needed
for reliable estimates of HIV prevalence and size of
populations at risk for infection.
Methods: The quality of countries’ surveillance systems
was scored using information from 2001 through 2007.
Sero-surveillance data were compiled from the US Census
Bureau’s HIV/AIDS Surveillance Database, from countries’
national HIV surveillance reports available to UNAIDS,
from demographic and health survey (DHS) data, from the
scientific literature and from countries’ Estimation and
Projection Programme (EPP) data files. The quality of
systems was scored according to the classification of the
epidemic in each country (generalised, concentrated or
low-level).
Result: The number of countries categorised as fully
functioning in 2007 was 40. 43 countries were identified
as partially functioning while 44 were categorised as
poorly functioning. Low scores were most often attributed
to a lack of recent data or data from appropriate risk
groups.
Conclusion: Many countries still have poorly functioning
surveillance systems. The inclusion of HIV testing in
national population-based surveys in recent years has
resulted in some countries with generalised epidemics
receiving higher coverage scores, but many countries with
concentrated or low-level epidemics continue to lack data
on high-risk populations.
Tracking and monitoring the HIV epidemic
remains heavily dependent upon the quality of
national surveillance. As noted in earlier reports,
12
one purpose of HIV surveillance is to determine the
magnitude of the epidemic. Twenty-five years
since the start of the epidemic, a more important
purpose is to track the changes or trends in the
epidemic over time. Assessing trends in HIV
prevalence is important for assessing the demo-
graphic impact of the epidemic, for predicting the
future course of the epidemic, for determining
resource allocation, as well as for monitoring the
impact of interventions and country responses.
Ingeneralisedepidemics,sentinelHIVsurveillance
among the general population can provide essential
information for planning care and support and for
indicating the success of the current response.
Surveillance based on women attending antenatal
clinics can be used toassesstrends in HIV prevalence
over time. Antenatal clinic surveillance has also been
used to estimate the population levels of HIV.
3
While countries with concentrated or low-level
epidemics often rely on case reporting to track their
epidemics, surveillance systems that rely solely on
AIDS or HIV case reporting are not effective because
of the long incubation period between infection and
the development of AIDS, and because people who
are infected with HIV are often not detected until
they become sick with AIDS. In addition, as noted
by other authors,
12 in low-income and middle-
income countries, health infrastructure is often not
developed well enough to allow the levels of
completeness that are required to make AIDS or
HIV case reporting a reliable measure of existing
levels or trends in the epidemic.
In countries with generalised epidemics, sentinel
surveillance of pregnant women attending public
health antenatal clinics has been recommended for
monitoring the course of the epidemic since the mid-
1980s.
4 Since 2000, UNAIDS and the World Health
Organization have promoted the use of second-
generationsurveillancetools
5tohelpcountriesunder-
stand their respective epidemics through the collec-
tion and analysis of surveillance data from different
sources.Thisinformationcanimprovetheabilityina
country to monitor trends in HIV prevalence as well
as to monitor the impact of the epidemic.
Since the quality of surveillance in Western
Europe, the United States, Canada, Australia and
other high-income countries have been analysed
and reported elsewhere,
6–9 this paper reanalyses the
quality of HIV surveillance systems in low-income
and middle-income countries only. Quality of
surveillance in low-income and middle-income
countries has been assessed before, in 1999 and
2002,
12utilising data almost exclusively from the
HIV surveillance database of the United States
Census Bureau and country reports on HIV and
AIDS available at the time to WHO and UNAIDS.
The data produced by these systems are often the
basis for the estimates of HIV prevalence and
impact produced by WHO and UNAIDS.
10 These
estimates are then used in turn to develop out-
comes related to the disease, such as mortality,
orphans, impact of treatment.
11 The paper will not
review the methods used to produce estimates of
HIV prevalence, which are presented elsewhere in
this supplement, nor will it review other aspects
(such as the impact of stigma, access to services or
rates of refusal) of surveillance related to HIV.
This main objective of this paper is to score the
quality of surveillance systems in low-income and
middle-income countries and to identify gaps in
the data that are needed to guide future research
and infrastructure development.
METHODS
Data sources
Data on surveillance of HIV in countries come
from a number of sources. In addition to the HIV
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(http://www.census.gov/ipc/www/hivaidsn.html), all coun-
tries participating in the UNAIDS/WHO bi-annual training
workshops on HIV estimation methods were asked to provide
up-to-date information on the surveillance activities and reports
in their countries. Additionally, all participants were followed
up by email in which they were provided with a country score
from the last round of assessment in 2004, a copy of all
documents used to develop the last score and that have been
received from the countries since then, and a request to provide
more recent documents should they exist. Finally, literature
searches were conducted for recent studies on high-risk
populations.
Epidemic classification
The countries were classified according to the state of the HIV
epidemic: low-level, concentrated or generalised. These defini-
tions were initially based on epidemic levels in countries and are
used to determine the most appropriate surveillance activities
needed in countries—that is, identifying which data and
population groups need to be included in surveillance.
5 Briefly,
in countries with low-level epidemics, HIV prevalence has not
consistently exceeded 5% in any subpopulation whose beha-
viour places them at highest risk for infection. At this level of
the epidemic, HIV surveillance should be carried out in the
groups at highest risk in the country.
An epidemic is referred to as concentrated if the estimated
HIV prevalence is consistently over 5% in at least one
subpopulation at highest risk of infection, and has a prevalence
below 1% in the general adult population (age 15–49 years) in
urban areas. At this level of the epidemic, surveillance should
continue in the groups at highest risk and surveillance should be
started in the general populations in urban areas.
In countries with generalised epidemics, HIV prevalence is
firmly established in the general adult population, and HIV
surveillance activities should be conducted among adults in the
general population in urban as well as rural areas
In countries with generalised epidemics, HIV prevalence data
from pregnant women attending antenatal clinics have been
used to monitor epidemic trends in the general adult popula-
tion.
12 While antenatal clinic surveillance only provides informa-
tion on women of reproductive age, population-based or
community-based studies which compare prevalence in samples
of men and women in the general population have been used to
calibrate the relation between this sample and the general
population. In recent years, many countries have also included
HIV testing in national population-based household surveys in
an attempt to obtain geographically more representative data
from adult populations.
Defining the quality of sentinel surveillance systems
In the past, coding schemes representing four dimensions
related to the quality of the surveillance system were developed
by Walker et al.
1 These dimensions, also used to score quality in
this paper, are:
c Frequency and timeliness of data collection;
c Appropriateness of populations under surveillance;
c Consistency of the sites/location and groups measured over
time; and
c Coverage/representativeness of the groups for the adult
populations.
Scoring surveillance quality in countries with generalised
epidemics
Initial coding of the data
A spreadsheet was developed for each country to record
available data for each year during the time period of interest
(2001–7) (frequency and timeliness), the type of data available
(appropriateness of populations under surveillance), consistency
of the sites included in surveillance and the representativeness
of the sites. Different spreadsheets were used for low level/
concentrated epidemics and generalised epidemics, with the low
level/concentrated epidemic spreadsheets allowing the reviewer
to identify which high-risk populations had been included in
surveillance.
Scoring sentinel surveillance quality
Scores were computed for each of the four dimensions of
quality, which were then combined to create an overall score of
the quality of the surveillance system for each country included
in this process.
Frequency and timeliness
The scoring for frequency and timeliness remained a simple
arithmetic calculation. The number of times national sentinel
surveillance or a national population-based HIV prevalence
survey had been conducted between 2001 and 2007 was counted
(range 0 to 7). This total was then divided by the potential
maximum (7) to obtain a ratio between 0 and 1. Since frequency
was deemed important for trend analysis, this value was then
doubled. Countries where data had been collected in the last
two years were given an additional 1, others 0 for timeliness.
The sum of these two values (with a maximum of 3) was used
as the overall measure of frequency and timeliness.
Appropriateness
An appropriate surveillance system was defined as one in which
data had been collected in the last seven years in urban as well
as rural sites from antenatal clinic surveillance. In this round of
assessment, if a national population-based survey had been
conducted between 2001 and 2007, it was also counted as
‘‘appropriate’’. Countries with an appropriate system were
scored as 1, all others were scored as 0.
Consistency
Scoring for consistency was a judgment made by the reviewer of
the country data. As stated by other authors,
12trends in the
epidemic cannot be accurately measured if data are not collected
repeatedly from the same sites over time. The score for
consistency was made on a 3-point scale, with 0 representing
no pattern of consistency in urban and rural sites from
antenatal clinic surveillance, a score of 1 was given when there
was some repetition in sites and where it could be determined
that the data provided some information about trends, and a
score of 2 was given for surveillance systems where a clear
pattern of consistency was evident. This value was divided by 2
(the maximum score) to obtain a ratio between 0 and 1. A score
of 1 suggests that there was sufficient consistency among sites
to measure trends in the epidemic among pregnant women in
both urban and rural areas. Judgments of consistency were
made independently by two reviewers.
Coverage
Coverage was scored differently in this round of assessment
compared to the assessment in 2004. Coverage was scored on a
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some evidence of an increasing surveillance capacity, 2 if the
surveillance system in antenatal clinics is fully representational
in urban and rural areas, and 3 if a DHS or national population-
based survey with HIV testing was conducted in addition to
sentinel surveillance. This value was then divided by 3 (the
maximum score) to obtain a ratio between 0 and 1.
Overall quality of the surveillance systems in generalised epidemics
The overall quality of the surveillance system was determined
by the sum of the scores for each of the four dimensions. The
sum of these four dimensions ranged from 0 to 6, with
frequency and timeliness contributing to half of the total. As in
the past, three categories of quality were used; fully implemen-
ted, partially implemented and poorly implemented. Countries
scoring more than 4 out of 6 were regarded to be fully
functioning, representing surveillance systems that were timely,
frequent, appropriate and representative. Countries scoring
from 2 to 3.9 were rated as partially implemented, characterised
by having some features of a high-quality system, but not all.
Many of these countries needed more frequent surveillance.
Countries scoring lower than 2 were characterised as poorly
functioning in which none of the countries were determined to
have sufficient data to track the trends in the epidemic. As a
result of this analysis, gaps in surveillance systems can be
identified and utilised to enhance country-specific surveillance
systems.
Scoring surveillance quality in countries with concentrated and
low-level epidemics
Scoring quality of surveillance systems in countries with low-
level or concentrated epidemics was different from scoring for
countries with generalised epidemics (fig 1). In countries with
low-level or concentrated epidemics, the risk of infection is
concentrated in groups that report behaviours associated with
HIV infection. Information needed for monitoring the trends in
the epidemic in these countries must therefore come from
groups at higher risk for infection.
Initial coding of data
A separate spreadsheet was used for countries with low-level or
concentrated epidemics. Surveillance systems in these countries
were assessed based on the presence of data from four of the
groups most at risk for infection: commercial sex workers
(CSW), clients of CSW, men who have sex with men (MSM)
and injecting drug users (IDUs). Data were also collected on
surveillance conducted among patients seeking care for sexually
transmitted infections (STI), which might serve as a proxy for
high-risk individuals in some settings. For each category, the
years in which data were collected were also recorded.
Scoring surveillance system quality
As for countries with generalised epidemics, quality of
surveillance systems in low-level or concentrated epidemics
were scored based on the four dimensions outlined above.
Frequency was scored as described above, as was timeliness, with
a summed score ranging between 0 and 2, but assessing
surveillance systems among population at higher risk for
infection over time.
Appropriateness and coverage were combined and defined by
those populations that had been under surveillance. In low-level
and concentrated epidemics it has been determined that it is not
necessary to be concerned about full geographical coverage,
since these populations are often clustered in urban areas.
13–15
Therefore, if all high-risk populations were reported on, full
scores (with a maximum of 4) were awarded in appropriateness
and coverage. If some high-risk populations were not consid-
ered, lower scores were awarded. For countries to receive the
highest score (3) at least three risk groups and pregnant women
in urban areas would have to be included in surveillance. For a
score of 3, the surveillance system must include data from three
high-risk groups, MSM, IDU and CSW; for a score of 2, a
country surveillance system would include data from only one
high-risk group and some other source (for example, antenatal
clinics, prisons, migrant population, etc); for inclusion of only
one data source, countries received a score of 1; all other
countries received a 0 score. This score was divided by the
maximum (4) to obtain a ratio between 0 and 1.
For low-level epidemics, data should be collected from all
groups at risk for infection in order to be considered fully
implemented. For countries with concentrated epidemics, there
should also be surveillance among pregnant women in urban
areas.
As initially proposed by Walker et al,
1 consistency was again
judged by considering the reported sites over time. First, a
measure of consistency was estimated: if the same sites were
consistently included over time, 1 point was given, 2 was given
for some consistency and 3 was given for no or very little
consistent use of sites. Second, the number of times data had
been collected in any of the higher-risk populations over the last
seven years (with a maximum of 7) was counted and divided by
7, similar to the frequency score above. In this round of scoring,
the overall consistency score was then calculated by dividing the
frequency score by the measure of consistency (1, 2 or 3). Those
with greatest consistency received the largest score, those with
the weakest, the smallest. The overall score could range
between 0 and 1.
Overall quality of the sentinel surveillance systems—concentrated
and low-level epidemics
As in the case of countries with generalised epidemics, a
summary score was developed by combining different dimen-
sions of surveillance, with the total ranging between 0 and 4.
Different cut-off scores were used for concentrated and low-
level epidemics. For both concentrated and low-level epidemics,
poorly functioning surveillance systems received a score of 0 to
1.6, partially functioning systems were scored 1.7 to 3.3 and
fully functioning were score 3.4 or higher.
RESULTS
Results of the quality of HIV surveillance in 127 low-income
and middle-income countries are presented in table 1 by
geographical region. As shown in the table, 40 countries are
categorised as having generalised epidemics, 49 countries have
concentrated epidemics and 38 counties in this assessment have
a low-level HIV epidemic.
Among the 127 countries whose surveillance systems were
rated, 40 countries were judged to have fully functioning
surveillance systems; 43 have partially functioning systems and
44 were rated as having poorly functioning or non-existent
sentinel surveillance systems.
Sub-Saharan Africa
This region is the most affected by the HIV pandemic.
10 Among
the 44 countries scored in this region, all but six have generalised
epidemics. Twenty-four countries have systems that would be
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Country
State of
epidemic Quality rating
Caribbean
Bahamas C 2
Barbados C 1
Cuba C 1
Dominican Republic C 3
Haiti G 3
Jamaica C 1
Trinidad and Tobago C 1
East Asia and Pacific
China C 3
Fiji L 1
Mongolia L 1
Papua New Guinea C 2
Eastern Europe and Central Asia
Armenia C 2
Azerbaijan L 1
Belarus C 2
Bosnia and Herzegovina L 1
Georgia L 2
Kazakhstan C 2
Kyrgyzstan L 2
Republic of Moldova C 2
Romania L 1
Russian Federation C 2
Tajikistan L 2
Turkmenistan L 1
Ukraine C 3
Uzbekistan C 2
Latin America
Argentina C 3
Belize C 2
Bolivia L 1
Brazil C 3
Chile C 1
Colombia C 2
Costa Rica C 1
Ecuador C 2
El Salvador C 2
Guatemala C 2
Guyana C 2
Honduras C 2
Mexico C 3
Nicaragua C 1
Panama C 1
Paraguay C 2
Peru C 3
Suriname C 2
Uruguay C 2
Venezuela C 1
North Africa and Middle East
Algeria L 1
Bahrain L 1
Cyprus L 1
Egypt L 2
Iraq L 1
Israel C 1
Jordan L 1
Kuwait L 1
Lebanon L 1
Libyan Arab Jamahiriya L 1
Morocco L 2
Oman L 1
Continued
Table 1 Continued
Country
State of
epidemic Quality rating
Qatar L 1
Saudi Arabia L 1
Sudan G 1
Syrian Arab Republic L 1
Tunisia L 1
Turkey L 1
United Arab Emirates L 1
Yemen L 1
South and South-East Asia
Afghanistan L 1
Bangladesh L 3
Bhutan L 1
Brunei Darussalam L 1
Cambodia C 3
India C 3
Indonesia C 2
Iran (Islamic Republic of) L 2
Lao Peoples’ Democratic Republic L 3
Malaysia C 2
Maldives L 1
Myanmar C 3
Nepal C 3
Pakistan L 2
Philippines L 2
Sri Lanka L 2
Thailand C 3
Vietnam C 3
Sub-Saharan Africa
Angola G 3
Benin G 3
Botswana G 3
Burkina Faso G 3
Burundi G 3
Cameroon G 2
Central African Republic G 2
Chad G 2
Comores C 1
Congo G 2
Cote d’Ivoire G 3
Democratic Republic of Congo G 2
Djibouti G 2
Equatorial Guinea G 2
Eritrea G 2
Ethiopia G 3
Gabon G 2
Gambia G 2
Ghana G 3
Guinea G 2
Guinea-Bissau G 1
Kenya G 3
Lesotho G 3
Liberia G 2
Madagascar C 1
Malawi G 3
Mali G 3
Mauritania C 1
Mauritius C 1
Mozambique G 3
Namibia G 3
Niger G 2
Nigeria G 3
Rwanda G 3
Continued
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region have conducted national population-based surveys in
which HIV testing has been included, which are often used to
adjust national HIV prevalence estimates based on ANC
sentinel surveillance data. A discussion of this process of
adjustment is presented elsewhere in this supplement.
16 Scores
in these countries were increased by additional points if a
population-based survey with HIV testing had been conducted.
The fully functioning system determinations were therefore
influenced by the availability of population-based prevalence
data. On the other hand, six countries do not have surveillance
systems that could be characterised as even partially function-
ing. These countries, though few in number, do not have basic
surveillance activities that will allow for tracking the epidemic.
Fourteen countries have partially functioning surveillance
systems. Countries with the highest HIV burden have the most
fully functioning surveillance systems.
Surveillance efforts in Chad and Cameroon have declined
considerably in the last three years. As a result, the surveillance
system in these two countries is categorised as only partially
functioning in this assessment. Namibia and Togo have
evidence of ongoing antenatal clinic surveillance, yet have not
conducted a national population-based survey, However, their
antenatal clinic surveillance is consistent, appropriate and
timely and, as such, these countries are determined to have
fully functioning surveillance systems.
South and South East Asia (excluding China and India)
Among the 18 countries assessed in this region, eight are
characterised as having fully functioning surveillance systems.
The epidemics in most of these countries are centred in high-risk
populations, are mature and, as such, surveillance of infections
and tracking of the epidemic are well established. Of the
remaining countries, six were partially implemented and four
were functioning poorly. The region as a whole has sufficient
data on IDU and CSW populations, but has limited information
on MSM populations.
China
The Chinese surveillance process has improved greatly over the
past decade. There are considerably more studies in the
literature that address population sizes for groups at highest
risk and in 2007 the national government released an estimate
Table 1 Continued
Country
State of
epidemic Quality rating
Senegal C 3
Sierra Leone G 2
Somalia C 1
South Africa G 3
Swaziland G 3
Togo G 3
Uganda G 3
United Republic of Tanzania G 3
Zambia G 3
Zimbabwe G 3
Figure 1 Quality of HIV surveillance systems, 2007.
Supplement
Sex Transm Infect 2008;84(Suppl I):i85–i91. doi:10.1136/sti.2008.030593 i89of HIV prevalence
17 in the country that represented a combined
estimate from all provincial-level estimation calculations. In this
round of assessments, China is rated as a fully functioning
surveillance system.
India
India has historically relied on data from sentinel surveillance to
monitor the epidemic. However, it has long been suggested that,
in fact, there was no single epidemic in the country, but many
different foci of infections that were regionally diverse. A recent
national population-based survey in the country provided a
more robust measure of the actual prevalence and, as such, the
estimated national prevalence was lowered.
18 19 Sentinel surveil-
lance systems have also improved significantly over time and
India is rated as having a fully functioning surveillance system.
Eastern Europe and Central Asia
The 14 countries in this region all continue to have low-level or
concentrated epidemics. The epidemics in Russia and the
Ukraine continue to grow, however, with Ukraine surpassing
a prevalence of 1.6%.
10 Of the countries in this region, nine have
developed at least partially functioning surveillance systems.
Four have poorly functioning systems, and only one, the
Ukraine, has a fully functioning system. Weaknesses in this
region are due in large part to the practice of utilising HIV and
AIDS case-reporting, and to the requirement of this assessment
methodology for longer-term tracking of the epidemic. There
are more studies coming from this region on particular high-risk
populations, but most of the gaps in the surveillance systems
are a result of the few studies in MSM populations.
Latin America and the Caribbean
There are 27 countries in this region, and unlike what has been
reported in the past,
1 in this round of assessment, only one
country is designated as generalised, while 26 are designated as
low-level or concentrated. Six are fully functioning, 11 are
partially functioning and 10 are poorly functioning.
North Africa and the Middle East
The 20 countries in this region all have low-level or concen-
trated epidemics. Although five countries have data available on
HIV prevalence in high-risk populations, only two of these
countries, Egypt and Morocco, have the quantity and quality of
data required to partially track the epidemic. There is a need to
conduct behavioural studies in the region to determine if the
behaviours placing individuals at risk for infection are rarely
present, or simply not visible.
20 There are a few studies among
CSW, but virtually none among MSM or IDU.
DISCUSSION
The analysis of the quality of surveillance systems for HIV
continues to reflect wide variations in monitoring the epidemic,
within and across regions. Fewer countries in this round of
assessment have been categorised as fully functioning (40 vs 48)
and fewer have been categorised as poorly functioning (44 vs 57)
compared to the previous round of assessment in 2004.
2 Over
68% of the global number of HIV infections are in sub-Saharan
Africa,
19 and in those countries with the highest HIV prevalence,
the surveillance systems are generally good. As such, estimates
of HIV prevalence and its impact in those countries, particularly
in countries that have also conducted national population-based
HIV surveys, are generally robust and of good quality. With
better surveillance data, HIV estimations in these countries
have improved over time and are continually adjusted as data
and assumptions are updated,
10 providing a more robust picture
of the global burden of disease. Indeed, the quality of
surveillance in many countries in this region has improved
owing to expanded sentinel surveillance systems as well as the
availability of information from national population-based
surveys in which HIV testing has been included.
Surveillance systems judged to be of higher quality are also
found in South and South East Asia. As in sub-Saharan Africa,
the epidemics in some countries in this region are older and
more mature than in other regions and surveillance systems in
the majority of these countries are well functioning. Only about
a third of the surveillance systems in Latin America and the
Caribbean have sufficient information to be a fully functioning
surveillance system. In the rest of the countries considered in
North Africa and the Middle East, and in Eastern Europe and
Central Africa, surveillance systems are either partially func-
tioning or not functioning well at all. The exception in Eastern
Europe was the Ukraine with a well functioning surveillance
system, particularly among IDU.
The results of this analysis reveal general overall weaknesses
in most (68%) of the evaluated countries’ surveillance systems.
The number of countries with low-level or concentrated
epidemics with studies considering MSM is limited almost
exclusively to countries in Latin America and South Asia. This is
also true for CSW. This may represent the true nature of the
disease burden, the focus of prevention interventions or may
represent populations more easily accessible and accepted by the
local culture. In countries in Central and Eastern Europe, the
preponderance of information about the epidemic comes from
studies focusing on IDU.
Additionally, even in those countries where data exist for the
populations most at risk of infection, consistent data collection
over time does not, and trends in the epidemic are difficult if not
impossible to monitor. Though the methodology used in this
assessment attempted to address representativeness and cover-
age of surveillance, the actual size of high-risk populations
remains difficult to quantify. Most HIV prevalence data in these
high-risk populations are found in specific studies with limited
sample size and limited sampling frames. Accurate extrapola-
tion of the results of these studies to the specific high-risk
population would require an estimate of the population size.
The value of data from studies such as these would be enhanced
by estimations of the size of the high-risk populations. Further,
just as correction factors have been suggested for prevalence
estimates based on ANC data using data from population-based
surveys, studies are needed to determine if such adjustments are
needed for estimations among high-risk populations (that is,
Workbook or EPP).
21 22
The analysis presented here has several limitations that must
be considered. First, there is the possibility that some data in
countries have not been considered in this analysis. Every effort
has been made to ensure that available data have been identified
by contacting national epidemiologists from each country and
requesting the most recent data available. The scope of the data
considered appropriate for the analysis in low-level or concen-
trated epidemics was limited to data on high-risk populations,
and for the analysis in generalised epidemics was focused on
antenatal clinic surveillance and population-based surveys that
include HIV testing. If a country uses data from other sources
for monitoring the epidemic, such as data related to blood
screening, those data were not captured here. Additionally,
publications were considered in English, French, Spanish and
Russian. Other languages were not considered.
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because of the asymptomatic nature of the infection for most of
the duration of the infection. For many individuals in countries
with low-level and concentrated epidemics, barriers to testing
(such as access and stigma) make it difficult to adequately assess
the true burden of infection in certain populations.
23 However,
with the increase in the availability of treatment, an increase in
the number of people undergoing counselling and testing and an
increase in the number of identified cases might be expected.
This paper considered the most recent data available for the
last seven years in assessing the quality of surveillance systems
for monitoring the HIV epidemic. In countries with the largest
disease burden, surveillance has continued to improve over time,
and the addition of large population-based HIV prevalence
surveys in these countries has greatly enhanced the reliability of
the data. In many other countries, specifically those with low-
level and concentrated epidemics, the quality of data has also
improved, though many countries still lack the consistency
required to follow trends over time in these high-risk popula-
tions. There are gaps in some countries’ data on high-risk
populations, and behavioural data are generally scarce.
Estimating the size of high-risk populations and the frequency
of exposure to HIV remains a difficult task.
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Key messages
c The quality of HIV surveillance seems to be improving.
c However, some countries still lack the necessary data to
accurately assess the course of the epidemic. Trend analyses
will be difficult.
c Many countries with low-level and concentrated epidemics
could improve their surveillance by collecting data from all
groups at risk for infection.
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